semaglutide kidney side effects and Survival Benefits of in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup Analyses Semaglutide just got FDA-approved for

The honest answer is more specific

The scope of research on this compound is currently limited to preclinical studies, with an absence of clinical data

The distinction matters because it means the peptide optimizes how cells respond to existing growth signals rather than flooding the system with additional signals

While it was originally approved by the FDA to treat diabetes, healthcare providers often prescribe it off-label to support weight loss, especially in people struggling with postmenopausal weight gain

Overall, large reviews have not shown a clear increased risk across the class, but you should call your doctor right away if you experience severe or unusual abdominal pain

During treatment, SBP typically showed reductions ranging from around 1 to 10 mmHg, although some studies fell outside this range